GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

The global alopecia (hair loss) treatment market is anticipated to grow at a CAGR of 5.51% between 2019 and 2027 and is estimated to generate revenue of $13,604 million by 2027. Alopecia is the condition where loss of hair occurs regardless of any age group across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia.

GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

Global Alopecia (Hair Loss) Treatment Market by Gender (Male Alopecia Treatment, Female Alopecia Treatment) by Sales Channel (Prescription, Over the Counter) by Treatment Type (Oral Hair Loss Treatment, Topical Hair Loss Treatment, Other Treatment Type) by Geography.

Request free sample

The global alopecia (hair loss) treatment market is anticipated to grow at a CAGR of 5.51% between 2019 and 2027 and is estimated to generate revenue of $13,604 million by 2027. Alopecia is the condition where loss of hair occurs regardless of any age group across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia. The following factors primarily drive the alopecia (hair loss) treatment market:

  • Technological advancements
  • Growth in the incidence and prevalence of chronic diseases
  • Change in lifestyle leading to a surge in the use of alopecia drugs

Alopecia (Hair Loss) Treatment market

To know more about this report, request a free sample copy

The important drivers increasing growth in the global alopecia (hair loss) treatment market are the growth in the incidence and prevalence of chronic diseases and change in lifestyle leading to a surge in the use of alopecia drugs. Growth in the incidence and prevalence of chronic diseases such as Polycystic Ovary Syndrome (PCOS), Rheumatoid Arthritis and cancer is driving the alopecia treatment market. Modern lifestyle changes such as physical inactivity and stress can lead to the development of alopecia.

The alopecia (hair loss) treatment types are used extensively for the treatment of hair loss. The rapidly increasing number of population suffering from arthritis upsurges the demand of arthritis medication, which is further responsible for hair loss. The oral hair loss treatment types are segmented into Finasteride and other forms of oral hair loss treatment. Finasteride helps in minimizing the activity of DHT on the scalp. Other oral hair loss treatment includes products such as biotins which are sold in the form of tablets.

The topical treatment is much more affordable, which is mainly responsible for this segment to hold the largest share in the alopecia market. The topical treatment types is further segmented into Minoxidil and shampoos. Minoxidil dilates small blood vessels. It is applied to the affected area of the scalp daily as it stimulates hair regrowth by enhancing cell proliferation. The shampoo containing Anthralin should be applied on the skin and left for 20 to 60 minutes depending on the instructions by the doctor.

Growing preference toward surgeries and restrictions on approved therapies are the majorly hindering the alopecia (hair loss) treatment market. Most of the individuals’ perception toward surgeries for the treatment of alopecia has changed a lot owing to their permanent curative options compared with drug therapies. The market has only one approved therapy, and there are huge unmet requirements that are supposed to be addressed.

The global alopecia (hair loss) treatment market segments cover the treatment type, gender, and sales channel.

Treatment type is segmented into:

  • Oral hair loss treatment
    • Finasteride
    • Other oral hair loss treatment
  • Topical hair loss treatment
    • Minoxidil
    • Shampoos
  • Other treatment type

Gender is segmented into:

  • Male Alopecia Treatment
  • Female Alopecia Treatment

Sales Channel is segmented into:

  • Prescription
  • Over the Counter

This report covered the present market conditions and the growth prospects of the global alopecia (hair loss) treatment market for 2019-2027 and considered the revenue generated through the sales of alopecia (hair loss) treatment for treatment type, gender and sales channel to calculate the market size by considering 2018 as the base year.

Geographically, the global alopecia (hair loss) treatment market has been segmented on the basis of four major regions, which include:

The alopecia (hair loss) treatment market in North America is expected to hold the largest share by 2027. The possibilities of the rising incidence of chronic diseases in the region, such as polycystic ovary syndrome (PCOS), cancer, and rheumatoid arthritis further lead to alopecia. The increasing investment in research and development (R&D) coupled with the augmented healthcare facilities are contributing to the largest share of this region over the market. The North America market constitutes a share of approx. 46% in 2018. The U.S. dominated the overall market of North America in 2018, due to the increasing prevalence of androgenetic alopecia and alopecia areata accompanied by the rising healthcare expenditure.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the alopecia (hair loss) treatment market. The Asia Pacific accounted for a smaller share of the overall market compared with other regions. This is primarily because people in this region prefer alternative traditional alopecia therapy, such as oil massage and hair mask, along with small pockets of the surgical and therapeutic option.

The alopecia (hair loss) treatment market is further segmented based on gender, which is sub-divided into male alopecia treatment and female alopecia treatment. Also, the segmentation on the basis of sales channel is further sub-divided into prescription and over the counter. Androgen, the male hormone, is one of the major reasons for androgenetic alopecia among males. Some of the major brands used by men for hair loss treatment are Rogaine, Lipogaine, Kirkland Minoxidil, Infinite Growth, and NuNutrient. Hair loss in women can occur at any age but, generally, 40% of women experience it by the age of 50. Some of the majorly prescribed hair loss medication is corticosteroids and Finasteride. FDA-approved OTC products for hair loss are raising the alopecia market growth.

The major market players of the global alopecia (Hair loss) treatment market are:

  • Johnson and Johnson
  • Alpecin
  • Daiichi Sankyo, Inc.
  • GlaxoSmithKline
  • Merck & Co., Inc.

The company profiles cover the market analysis of numerous important players.

The business line of Johnson and Johnson is distributed into three major segments: consumer healthcare, medical devices, and diagnostics & pharmaceuticals. Their consumer healthcare business has seven major franchises, Babycare, skin & hair care (alopecia), wound care & topical, women health, oral health care, over-the-counter (OTC) drugs, and nutritional products. Merck has published several manuals on alopecia treatment, and their major products for alopecia treatment are Propecia, corticosteroid lotions, and creams.

Key findings of the global alopecia (hair loss) treatment market:

  • Topical hair loss treatment is the most popularly prefered form of treatment
  • Female alopecia treatment market holds the largest market share
  • Over the counter is the fastest growing sales channel
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • TOPICAL HAIR LOSS TREATMENT IS THE MOST POPULAR AMONG CUSTOMERS
      • FEMALE ALOPECIA TREATMENT MARKET HOLDS THE LARGEST MARKET SHARE
      • OVER THE COUNTER IS THE FASTEST GROWING SALES CHANNEL
  1. MARKET DETERMINANTS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • TECHNOLOGICAL ADVANCEMENTS
      • GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
      • CHANGE IN LIFESTYLE LEADING TO A SURGE IN THE USE OF ALOPECIA DRUGS
    • MARKET RESTRAINTS
      • GROWING PREFERENCE TOWARD SURGERIES
      • RESTRICTED APPROVED THERAPIES
    • MARKET OPPORTUNITIES
      • GROWING HEALTHCARE EXPENDITURE
      • RISING PREVALENCE OF ALOPECIA
    • MARKET CHALLENGES
      • ALTERNATIVE HAIR LOSS THERAPIES
  1. MARKET BY GENDER
    • MALE ALOPECIA TREATMENT
    • FEMALE ALOPECIA TREATMENT
  2. MARKET BY SALES CHANNEL
    • PRESCRIPTION
    • OVER THE COUNTER
  3. MARKET BY TREATMENT TYPE
    • ORAL HAIR LOSS TREATMENT
      • FINASTERIDE
      • OTHER ORAL HAIR LOSS TREATMENT
    • TOPICAL HAIR LOSS TREATMENT
      • MINOXIDIL
      • SHAMPOOS
    • OTHER TREATMENT TYPE
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • MARKET TRENDS
      • PLATELET RICH PLASMA THERAPY (PRP)
      • INTRODUCTION OF NEW PRODUCTS
      • INCREASING USAGE OF REGENERATIVE MEDICINE
      • STEM CELL THERAPY USED FOR THE TREATMENT OF HAIR LOSS
      • EMERGENCE OF LASER TECHNOLOGY
    • PETL ANALYSIS
      • POLITICAL & LEGAL
      • ECONOMIC
      • TECHNOLOGICAL
    • ALOPECIA TREATMENT PURCHASE DECISION ANALYSIS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • THE UNITED KINGDOM
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ACLARIS THERAPEUTICS INC.
      • ALÈS GROUPE
      • ALPECIN
      • CIPLA
      • CONCERT PHARMACEUTICALS INC.
      • DAIICHI SANKYO, INC.
      • DR REDDY’S LABORATORIES LTD.
      • GLAXOSMITHKLINE
      • HCELL INC.
      • HISTOGEN INC.
      • JOHNSON AND JOHNSON
      • LIFES2GOOD
      • MERCK & CO., INC.
      • SUN PHARMACEUTICAL INDUSTRIES LTD.
      • VITABIOTICS LTD.

LIST OF TABLES

TABLE 1        GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)

TABLE 3        GLOBAL MALE ALOPECIA TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL FEMALE ALOPECIA TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY SALES CHANNEL 2019-2027 ($ MILLION)

TABLE 6        GLOBAL PRESCRIPTION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL OVER THE COUNTER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY TREATMENT TYPE 2019-2027 ($ MILLION)

TABLE 9        GLOBAL ORAL HAIR LOSS TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL ORAL HAIR LOSS TREATMENT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 11      GLOBAL FINASTERIDE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12      GLOBAL OTHER ORAL HAIR LOSS TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL TOPICAL HAIR LOSS TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14      GLOBAL TOPICAL HAIR LOSS TREATMENT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 15      GLOBAL MINOXIDIL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL SHAMPOOS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      GLOBAL OTHER TREATMENT TYPE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 20      EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 21      ASIA PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 22      REST OF THE WORLD ALOPECIA (HAIR LOSS) TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23      ALOPECIA (HAIR LOSS) TREATMENT COMPANY MARKET POSITION ANALYSES 2017

FIGURE LIST

FIGURE 1      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 2      IMPACT OF ALCOHOL ON HAIR LOSS

FIGURE 3      NATIONAL HEALTHCARE SPENDING IN THE UNITED STATES, 2015-2025 (% OF GDP)

FIGURE 4      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET SHARE BY GENDER 2018 & 2027 (%)

FIGURE 5      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY MALE ALOPECIA TREATMENT 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY FEMALE ALOPECIA TREATMENT 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET SHARE BY SALES CHANNEL 2018 & 2027 (%)

FIGURE 8      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET SHARE BY TREATMENT TYPE 2018 & 2027 (%)

FIGURE 11   GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY ORAL HAIR LOSS TREATMENT 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL ORAL HAIR LOSS TREATMENT MARKET BY FINASTERIDE 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL ORAL HAIR LOSS TREATMENT MARKET BY OTHER ORAL HAIR LOSS TREATMENT 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY TOPICAL HAIR LOSS TREATMENT 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL TOPICAL HAIR LOSS MARKET BY MINOXIDIL 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL TOPICAL HAIR LOSS MARKET BY SHAMPOOS 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET BY OTHER TREATMENT TYPE 2019-2027 ($ MILLION)

FIGURE 18   PORTER’S FIVE FORCE MODEL

FIGURE 19   GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 20   THE UNITED STATES ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 21   CANADA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 22   GERMANY ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 23   THE UNITED KINGDOM ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 24   FRANCE ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 25   ITALY ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 26   SPAIN ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 27   REST OF EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 28   JAPAN ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 29   CHINA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 30   INDIA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 31   AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 32   SOUTH KOREA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 33   REST OF ASIA PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 34   LATIN AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 35   MIDDLE EAST AND AFRICA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

  1. MARKET BY GENDER
    • MALE ALOPECIA TREATMENT
    • FEMALE ALOPECIA TREATMENT
  2. MARKET BY SALES CHANNEL
    • PRESCRIPTION
    • OVER THE COUNTER
  3. MARKET BY TREATMENT TYPE
    • ORAL HAIR LOSS TREATMENT
      • FINASTERIDE
      • OTHER ORAL HAIR LOSS TREATMENT
    • TOPICAL HAIR LOSS TREATMENT
      • MINOXIDIL
      • SHAMPOOS
    • OTHER TREATMENT TYPE
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • THE UNITED KINGDOM
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now